Studies suggest that vitamin D (VitD) may reduce oxidative stress (OS) in multiple sclerosis (MS) patients. This study aimed to compare the effects of various VitD doses on OS in relapsing-remitting MS (RRMS). A 6-month supplementation was introduced using two doses of VitD: 2000 IU/day in the high-dose group (HD, = 23) and 15,960 IU/month in the low-dose group (LD, = 29).
View Article and Find Full Text PDFAims: Parsonage Turner Syndrome (PTS) is a peripheral neuropathy manifesting as sudden onset pain, muscle weakness, and atrophy. This review aims to analyse long-term outcomes reported in adult patients with PTS, and establish an optimised management approach.
Methods: A comprehensive literature search was performed using MEDLINE, PubMed, and the Cochrane Library.
Permanent inflammatory demyelinating and neurodegenerative processes lead to neurological disability in patients with multiple sclerosis (MS). The anti-inflammatory properties of vitamin D (VitD) are well established, but its role in neurodegeneration is still uncertain. The usefulness of the serum concentration of VitD as a potential biomarker in evaluating brain injury in terms of recently known smoldering MS was under consideration.
View Article and Find Full Text PDFBenthic organisms typically possess a planktonic propagule stage in the form of larvae or spores, which enables them to spread over large distances before settlement, and promotes tight pelago-benthic coupling. However, factors driving dispersal and epibenthos recruitment in shallow hard-bottom Arctic communities are poorly known. We therefore conducted a year-round in situ colonization experiment in Isfjorden (Svalbard), and found out that variation in early-stage epibenthic assemblages was explained by the combination of: abiotic (45.
View Article and Find Full Text PDF